A Phase II Trial Evaluating the Efficacy of Cabozantinib With Patients With Refractory GCTs

Conditions:   Germ Cell Tumor;   Seminoma;   Non-seminomatous Germ Cell Tumor;   Ovarian Germ Cell Tumor Intervention:   Drug: Cabozantinib Sponsors:   Nabil Adra;   Exelixis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials